Table of Contents
1 Study Coverage
1.1 C1 Esterase Inhibitor Product Introduction
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global C1 Esterase Inhibitor Market Size Growth Rate by Type
1.4.2 Human
1.4.3 Recombinant
1.5 Market by Application
1.5.1 Global C1 Esterase Inhibitor Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global C1 Esterase Inhibitor Market Size
2.1.1 Global C1 Esterase Inhibitor Revenue 2014-2025
2.1.2 Global C1 Esterase Inhibitor Sales 2014-2025
2.2 C1 Esterase Inhibitor Growth Rate by Regions
2.2.1 Global C1 Esterase Inhibitor Sales by Regions
2.2.2 Global C1 Esterase Inhibitor Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 C1 Esterase Inhibitor Sales by Manufacturers
3.1.1 C1 Esterase Inhibitor Sales by Manufacturers
3.1.2 C1 Esterase Inhibitor Sales Market Share by Manufacturers
3.2 C1 Esterase Inhibitor Revenue by Manufacturers
3.2.1 C1 Esterase Inhibitor Revenue by Manufacturers (2014-2019)
3.2.2 C1 Esterase Inhibitor Revenue Share by Manufacturers (2014-2019)
3.3 C1 Esterase Inhibitor Price by Manufacturers
3.4 C1 Esterase Inhibitor Manufacturing Base Distribution, Product Types
3.4.1 C1 Esterase Inhibitor Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers C1 Esterase Inhibitor Product Type
3.4.3 Date of International Manufacturers Enter into C1 Esterase Inhibitor Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type
4.1 Global C1 Esterase Inhibitor Sales by Type
4.2 Global C1 Esterase Inhibitor Revenue by Type
4.3 C1 Esterase Inhibitor Price by Type
5 Breakdown Data by Application
5.1 Overview
5.2 Global C1 Esterase Inhibitor Breakdown Data by Application
6 North America
6.1 North America C1 Esterase Inhibitor by Country
6.1.1 North America C1 Esterase Inhibitor Sales by Country
6.1.2 North America C1 Esterase Inhibitor Revenue by Country
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America C1 Esterase Inhibitor by Type
6.3 North America C1 Esterase Inhibitor by Application
7 Europe
7.1 Europe C1 Esterase Inhibitor by Country
7.1.1 Europe C1 Esterase Inhibitor Sales by Country
7.1.2 Europe C1 Esterase Inhibitor Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe C1 Esterase Inhibitor by Type
7.3 Europe C1 Esterase Inhibitor by Application
8 Asia Pacific
8.1 Asia Pacific C1 Esterase Inhibitor by Region
8.1.1 Asia Pacific C1 Esterase Inhibitor Sales by Region
8.1.2 Asia Pacific C1 Esterase Inhibitor Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Thailand
8.1.10 Malaysia
8.1.11 Philippines
8.1.12 Vietnam
8.2 Asia Pacific C1 Esterase Inhibitor by Type
8.3 Asia Pacific C1 Esterase Inhibitor by Application
9 Central & South America
9.1 Central & South America C1 Esterase Inhibitor by Country
9.1.1 Central & South America C1 Esterase Inhibitor Sales by Country
9.1.2 Central & South America C1 Esterase Inhibitor Revenue by Country
9.1.3 Brazil
9.2 Central & South America C1 Esterase Inhibitor by Type
9.3 Central & South America C1 Esterase Inhibitor by Application
10 Middle East and Africa
10.1 Middle East and Africa C1 Esterase Inhibitor by Country
10.1.1 Middle East and Africa C1 Esterase Inhibitor Sales by Country
10.1.2 Middle East and Africa C1 Esterase Inhibitor Revenue by Country
10.1.3 Turkey
10.1.4 GCC Countries
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa C1 Esterase Inhibitor by Type
10.3 Middle East and Africa C1 Esterase Inhibitor by Application
11 Company Profiles
11.1 CSL Behring
11.1.1 CSL Behring Company Details
11.1.2 Company Business Overview
11.1.3 CSL Behring C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2014-2019)
11.1.4 CSL Behring C1 Esterase Inhibitor Products Offered
11.1.5 CSL Behring Recent Development
11.2 Lev Pharmaceuticals
11.2.1 Lev Pharmaceuticals Company Details
11.2.2 Company Business Overview
11.2.3 Lev Pharmaceuticals C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Lev Pharmaceuticals C1 Esterase Inhibitor Products Offered
11.2.5 Lev Pharmaceuticals Recent Development
11.3 Salix Pharmaceuticals
11.3.1 Salix Pharmaceuticals Company Details
11.3.2 Company Business Overview
11.3.3 Salix Pharmaceuticals C1 Esterase Inhibitor Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Salix Pharmaceuticals C1 Esterase Inhibitor Products Offered
11.3.5 Salix Pharmaceuticals Recent Development
12 Future Forecast
12.1 C1 Esterase Inhibitor Market Forecast by Regions
12.1.1 Global C1 Esterase Inhibitor Sales Forecast by Regions 2019-2025
12.1.2 Global C1 Esterase Inhibitor Revenue Forecast by Regions 2019-2025
12.2 C1 Esterase Inhibitor Market Forecast by Type
12.2.1 Global C1 Esterase Inhibitor Sales Forecast by Type 2019-2025
12.2.2 Global C1 Esterase Inhibitor Revenue Forecast by Type 2019-2025
12.3 C1 Esterase Inhibitor Market Forecast by Application
12.4 North America C1 Esterase Inhibitor Forecast
12.5 Europe C1 Esterase Inhibitor Forecast
12.6 Asia Pacific C1 Esterase Inhibitor Forecast
12.7 Central & South America C1 Esterase Inhibitor Forecast
12.8 Middle East and Africa C1 Esterase Inhibitor Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 C1 Esterase Inhibitor Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
【掲載企業】
CSL Behring、Lev Pharmaceuticals、Salix Pharmaceuticals